- Feb 21, 2010
- 1,007
- 0
- 0
Now that the FDA has submitted some letters rogatory to the AFLD to obtain "Lance" urine, how about we focus in on what they will be doing with it.
Depending on how much whizz remains ( A/B or just B samples) this will decide what can be done. Science types who can speak to how much volume "might" remain, how much volume is necessary per test, would be much appreciated.
My thoughts:
1. CIR all samples - recall, they don't need an adverse T/E to jump to this test.
2. EPO test
3. CERA test (if this is not part of the EPO test)
4. Plasticizer test - cross-checking against "alleged" transfusion dates seems the likely way to go.
5. DNA test - gotta be sure it is "his" whizz...
More?
Depending on how much whizz remains ( A/B or just B samples) this will decide what can be done. Science types who can speak to how much volume "might" remain, how much volume is necessary per test, would be much appreciated.
My thoughts:
1. CIR all samples - recall, they don't need an adverse T/E to jump to this test.
2. EPO test
3. CERA test (if this is not part of the EPO test)
4. Plasticizer test - cross-checking against "alleged" transfusion dates seems the likely way to go.
5. DNA test - gotta be sure it is "his" whizz...
More?